Targets Reduce Scope 1 and 2 Emissions by 60% and Scope 3 by 35% by 2034

GeoYoung, a domestic pharmaceutical distribution company, announced on August 26 that it has published its first-ever sustainable management report since its foundation.


The "2025 GeoYoung Sustainable Management Report" includes the current status and major achievements of ESG (Environmental, Social, and Governance) management, as well as medium- to long-term action plans. The report was prepared in accordance with the international sustainability reporting standard, GRI Standards, and underwent third-party verification based on AA1000AS v3.

2025 GeoYoung Sustainable Management Report Cover Image. GeoYoung

2025 GeoYoung Sustainable Management Report Cover Image. GeoYoung

View original image

GeoYoung conducted a "double materiality assessment" that evaluates both the impact of corporate activities on the environment and society, and the influence of ESG issues on its management, to identify eight core issues. The company selected "ensuring the stability of pharmaceutical supply and managing business continuity" as the top priority. Other core issues highlighted include securing distribution quality and customer trust, strengthening information protection and personal data privacy, improving safety, health, and working conditions, and fostering win-win partnerships and responsible supply chain management with partners.


In the environmental sector, the report presents an implementation plan for the SBTi greenhouse gas reduction targets, for which GeoYoung became the first in the domestic pharmaceutical distribution industry to receive approval last year. GeoYoung plans to reduce Scope 1 and 2 emissions from vehicle operation and logistics center activities by 60% and Scope 3 emissions from procurement, transportation, and related supply chain activities by 35% by 2034. Last year, the company also obtained ISO 14001, the international certification for environmental management systems.


In the social sector, GeoYoung introduced its pharmaceutical distribution quality management, efforts for human rights management, win-win partnerships with partners, and safety and health initiatives. Last year, it also acquired ISO 45001, the international certification for occupational health and safety management systems.


In the governance sector, the company outlined plans to strengthen its board operation system based on four main principles: expertise, independence, accountability, and transparency. It also intends to advance its frameworks for ethical, compliance-based management and risk management.


GeoYoung also presented a medium- to long-term roadmap to advance its ESG management in four stages by 2035. The company aims to complete the establishment of an ESG management system by 2027, implement a key performance indicator (KPI)-based evaluation system by 2030, and then expand ESG management across all business operations.



GeoYoung Chairperson Sunhye Cho said, "Pharmaceutical distribution is directly linked to public health and the stable operation of medical institutions, which has raised the level of societal expectations for corporate social responsibility," and added, "We will make ESG management a core principle for sustainable growth and fulfilling our social responsibilities."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing